6-METHYL-1H-INDAZOL-4-YL-4-BORONIC ACID, 95.0%, 250mg

(2S,3R)-3-Fluoro-2-methylazetidine hydrochloride, 97%, 1g

5-Bromo-2-hydroxy-3-methyl-benzaldehyde, 98.0%, 25g

4-(2-Amino-benzoyl)-piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

4-Chloro-3-ethynylpyridine, 98%, 1g

Colonne capillaire GC ROTI®Cap-5, 30 m, 0,25 mm, 0,50 µm, 1 pièce(s)

1-(1-methyl-1H-1,2,4-triazol-5-yl)-1-propanone, 95.0%, 10g

1-(2,6-Dimethylphenyl)-2,2,2-trifluoroethan-1-ol, 5g

ethyl 7-amino[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate, 250mg

6-(tert-Butyl)-2-chloro-4-(trifluoromethyl)nicotinonitrile, 95.0%, 5g

6H-Thieno[2,3-b]pyrrole, 95.0%, 250mg

(6-Chloro-3-fluoropyridin-2-yl)methanamine, 97%, 1g

6-Bromo[1,3]thiazolo[5,4-b]pyridine, 97.0%, 1g